“Comparative pharmacoeconomic assessment of apixaban vs. standard of care for the prevention of stroke in Italian atrial fibrillation patients” (2014) Farmeconomia. Health economics and therapeutic pathways, 15(1S), pp. 15–26. doi:10.7175/fe.v15i1s.974.